On the West Coast, Tacoma, Washington residents have many health-conscious options. Rybelsus® is the FDA-approved Oral tablet Semaglutide product manufactured by Novo Nordisk, approved since 2019. Weight Method offers a separate telehealth program: licensed Washington providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for Tacoma starts at $199/month, including the provider evaluation, the medication, ongoing care, and home delivery.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Tacoma is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Tacoma, WA. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.
For many people in Tacoma, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Semaglutide addresses hormonal drivers involved in body weight regulation. Rybelsus® is the FDA-approved Oral tablet Semaglutide product by Novo Nordisk, approved in 2019 for Type 2 diabetes. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The program is priced at $199/month, including the evaluation, the medication, ongoing care, and home delivery to Tacoma.
City life in Tacoma brings convenience in many forms, but it also brings sedentary desk jobs, food delivery temptation, and stress-driven eating patterns that make weight management difficult. Semaglutide therapy works at the biological level — reducing hunger and cravings — so Tacoma residents can make better choices even during their busiest days. Weight Method prescribes compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy, at $199/month through virtual consultations that fit into a lunch break. Compounded Semaglutide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Washington and start Rybelsus from $199/month.
Get Started NowFree consultation. No commitment.